Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $5,695 - $6,517
-31 Reduced 31.31%
68 $14,000
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $256,365 - $347,253
-1,336 Reduced 93.1%
99 $20,000
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $282,852 - $358,850
1,435 New
1,435 $313,000
Q2 2022

Aug 02, 2022

BUY
$204.13 - $302.4 $17,555 - $26,006
86 Added 409.52%
107 $23,000
Q1 2022

May 11, 2022

BUY
$255.51 - $362.11 $5,365 - $7,604
21 New
21 $6,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.51B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.